Sign In
INO.US
id: 303

Inovio Pharmaceuticals (INO) Investor Settlement

It is still possible to file a late claim. The court will decide whether to accept late claims or not.
E.D. Pennsylvania
Court
2:20-cv-01402
Case number
14 Feb 2020
Class period Start
10 Aug 2020
Class period End
19 Dec 2022
Claim deadline
McDermid v. Inovio Pharmaceuticals, Inc., et al.

Inovio agreed to pay $30 million in cash and 7 million in stocks to settle a securities class action with Investors.

The class action alleged that during the period between February 14, 2020, and August 10, 2020, Inovio and its Leaders misled investors through a series of public statements regarding:
  • how quickly Inovio had designed and constructed the COVID-19 vaccine candidate;
  • Inovio’s capacity to manufacture large quantities,
  • the effectiveness of the vaccine candidate,
  • and the expected timeline for regulatory approval of the vaccine.
Specifically, the Complaint suspected that the Company capitalized on widespread COVID-19 fears by falsely claiming that Inovio had developed a vaccine. Inovio’s stock price rose significantly in response to these disclosures but plummeted when another company exposed Inovio’s misstatements and called for an SEC investigation.

On August 22, 2022, Inovio and Investors entered into a Stipulation of Settlement.

On August 31, 2022, the Court granted preliminary approval for the Settlement.
Case Status
Accepting Late Claims
Alleged Offence
Other
Suspected Party
Other
Security Type
Stocks
Trade Direction
Long
Plaintiffs
Manuel S. Williams, Andrew Zenoff
Attorneys
Robbins Geller Rudman & Dowd LLP, Saxton & Stump
Judge
Hon. Gerald J. Pappert
Administrator
Gilardi & Co LLC
Court hearing date
15 December 2022
Trades matching type
FIFO
+$30,000,000
Cash Settlement Amount
+7,000,000 stocks
Stocks Settlement Amount

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human ...

    Ticker
    INO.US
    ISIN
    US45773H4092
    CIK
    1055726
    Sector
    Healthcare
    Industry
    Biotechnology
    Country
    USA
    Address
    660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462